Ke Li

1.9k total citations
78 papers, 1.3k citations indexed

About

Ke Li is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Ke Li has authored 78 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 30 papers in Molecular Biology and 14 papers in Surgery. Recurrent topics in Ke Li's work include Pancreatic and Hepatic Oncology Research (8 papers), Cancer Cells and Metastasis (7 papers) and RNA modifications and cancer (6 papers). Ke Li is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Cancer Cells and Metastasis (7 papers) and RNA modifications and cancer (6 papers). Ke Li collaborates with scholars based in China, United States and Italy. Ke Li's co-authors include Dandan Dong, Shang-mian Yie, Hong Yang, Xinmei Lin, Yangying Liao, Hua Tang, Xiaopeng Xu, Meng Wu, Lan Li and Yue Han and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Ke Li

73 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Li China 20 460 370 242 241 164 78 1.3k
Yunshan Wang China 19 478 1.0× 482 1.3× 166 0.7× 340 1.4× 246 1.5× 55 1.5k
Chunxiang Li China 18 524 1.1× 327 0.9× 232 1.0× 232 1.0× 261 1.6× 83 1.3k
Xiaoli Hu China 20 697 1.5× 383 1.0× 296 1.2× 136 0.6× 201 1.2× 41 1.3k
Jing Jin China 24 555 1.2× 675 1.8× 238 1.0× 500 2.1× 210 1.3× 79 1.8k
Yi Chen China 22 448 1.0× 531 1.4× 326 1.3× 341 1.4× 325 2.0× 113 1.5k
Michaël Perrais France 22 1.2k 2.5× 392 1.1× 366 1.5× 266 1.1× 265 1.6× 39 1.8k
Haiping Yang China 22 694 1.5× 235 0.6× 332 1.4× 207 0.9× 275 1.7× 79 1.5k
Wiesława Niklińska Poland 23 577 1.3× 393 1.1× 271 1.1× 134 0.6× 333 2.0× 77 1.3k
Ling Xue China 26 797 1.7× 604 1.6× 273 1.1× 385 1.6× 223 1.4× 79 2.0k

Countries citing papers authored by Ke Li

Since Specialization
Citations

This map shows the geographic impact of Ke Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Li more than expected).

Fields of papers citing papers by Ke Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Li. The network helps show where Ke Li may publish in the future.

Co-authorship network of co-authors of Ke Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Li. A scholar is included among the top collaborators of Ke Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Li. Ke Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Cheng, Ming-Hui Ma, Ke Li, Shuning Xu, & Ying Liu. (2025). High dietary live microbe intake associated with reduced depressive symptoms in gastrointestinal disease patients: findings from a cross-sectional study. Nutrition & Metabolism. 22(1). 81–81. 1 indexed citations
4.
Li, Ke, et al.. (2023). ASPP1/2 positive patients with invasive breast cancers have good prognosis. Heliyon. 9(10). e20613–e20613. 1 indexed citations
5.
Wang, Xueqian, Chunxiao Cui, Beibei Wu, et al.. (2023). Chiral Supramolecular Hydrogel Enhanced Transdermal Delivery of Sodium Aescinate to Modulate M1 Macrophage Polarization Against Lymphedema. Advanced Science. 11(5). e2303495–e2303495. 9 indexed citations
6.
Feng, Hao, et al.. (2023). Identification of key circadian rhythm genes in skin aging based on bioinformatics and machine learning. Aging. 15(20). 11672–11689. 9 indexed citations
7.
Wang, Yingying, Yongqiang Hou, Wei Wang, et al.. (2021). Digoxin exerts anticancer activity on human nonsmall cell lung cancer cells by blocking PI3K/Akt pathway. Bioscience Reports. 41(10). 17 indexed citations
8.
Wang, Jing, et al.. (2020). Identification of WTAP-related genes by weighted gene co-expression network analysis in ovarian cancer. Journal of Ovarian Research. 13(1). 119–119. 13 indexed citations
9.
Chilgar, Ram M., Hung‐Chi Chen, Pedro Ciudad, et al.. (2019). Surgical Treatment of Advanced Lymphatic Filariasis of Lower Extremity Combining Vascularized Lymph Node Transfer and Excisional Procedures. Lymphatic Research and Biology. 17(6). 637–646. 9 indexed citations
10.
Li, Ke, et al.. (2019). <p>Inhibition of the hedgehog pathway for the treatment of cancer using Itraconazole</p>. OncoTargets and Therapy. Volume 12. 6875–6886. 21 indexed citations
11.
Jiang, Yanan, Jimin Zhao, Ke Li, et al.. (2018). Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study. Journal of Translational Medicine. 16(1). 138–138. 25 indexed citations
12.
Chen, Long, Yansheng Liu, Hongyan Yu, et al.. (2018). Integrated analysis of HPV-mediated immune alterations in cervical cancer. Gynecologic Oncology. 149(2). 248–255. 13 indexed citations
13.
Tang, Hua, Meng Wu, Yangying Liao, et al.. (2017). Ozone oil promotes wound healing by increasing the migration of fibroblasts via PI3K/Akt/mTOR signaling pathway. Bioscience Reports. 37(6). 131 indexed citations
14.
Pan, Linlin, et al.. (2017). Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis. PLoS ONE. 12(2). e0172413–e0172413. 11 indexed citations
15.
Li, Ke, Baiyong Shen, Xi Cheng, et al.. (2016). Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma. Cancer Research. 76(14). 4205–4215. 18 indexed citations
16.
Zhu, Hong‐Jian, Ke Li, Dandan Dong, et al.. (2014). Spindle cell metaplastic carcinoma of breast: A clinicopathological and immunohistochemical analysis. Asia-Pacific Journal of Clinical Oncology. 13(2). e72–e78. 10 indexed citations
17.
Guo, Wei, Bingshan Liu, Linlin Sun, et al.. (2013). Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer. Biomarkers. 18(2). 126–135. 14 indexed citations
18.
Li, Ke. (2009). Expression of oncogene c-erbB-2 and its relationship with clinicopathologic factors in infiltrating ductal breast cancer and metastatic axillary lymph nodes. 1 indexed citations
19.
Yang, Hong, et al.. (2007). Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Modern Pathology. 20(3). 375–383. 137 indexed citations
20.
Ouyang, Jingping, et al.. (2000). Effects of thyroid hormone on the myosin heavy chain mRNA expression in cardiac myocytes induced by angiotensin II. Zhongguo bingli shengli zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026